Detection of Squalene Epoxidase Mutations in United States Patients with Onychomycosis: Implications for Management
Journal of Investigative Dermatology · 2023-12 · 143 (12) · 2476-2483.e7
DOI: 10.1016/j.jid.2023.04.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2023-12. Verfasst von Aditya K Gupta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Mediprobe Research, London, Ontario, Canada. Electr…. Hauptthemen laut MEDLINE: Onychomycosis. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Resistance to oral terbinafine, the most commonly used antifungal to treat dermatophytosis and onychomycosis worldwide, is being increasingly reported. In this study, we aimed to investigate the species distribution and prevalence of squalene epoxidase mutations among toenail dermatophyte isolates. Samples from 15,683 patients suspected of onychomycosis visiting the offices of dermatologists and podiatrists in the United States were analyzed. Clinical information was reviewed, and dermatophyte species with or without squalene epoxidase mutations were detected using multiplex real-time PCRs. The frequency of dermatophytes was 37.6%; of isolates belonging to the Trichophyton genus, 88.3% were the T. rubrum complex, and 11.2% were the T. mentagrophytes complex. Individuals aged >70 years exhibited higher infection rates for the T. mentagrophytes complex. The overall mutation rate among Trichophyton spp. was 3.7%, with a higher mutation rate detected in the T. mentagrophytes complex (4.3 vs. 3.6%). Commonly detected mutations were T1189C/Phe397Leu (34.5%), T1306C/Phe415Ser (16.0%), and C1191A/Phe397Leu (11.0%). Squalene epoxidase gene mutations associated with decreased terbinafine susceptibility have been identified in United States patients with toenail onychomycosis. Physicians should be aware of the risk factors for resistance development and engage in antifungal stewardship practices such as directed diagnosis and treatment of dermatophytosis and onychomycosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Mediprobe Research, London, Ontario, Canada. Electronic address: agupta@mediproberesearch.com.
- Mediprobe Research, London, Ontario, Canada.
- Bako Diagnostics, Alpharetta, Georgia, USA.
- Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada.
Zitieren
APA
Gupta, A. K., Cooper, E. A., Wang, T., Polla Ravi, S., Lincoln, S. A., Piguet, V., McCarthy, L. R., & Bakotic, W. L. (2023). Detection of Squalene Epoxidase Mutations in United States Patients with Onychomycosis: Implications for Management. Journal of Investigative Dermatology, 143(12), 2476-2483.e7. https://doi.org/10.1016/j.jid.2023.04.032
Vancouver
Gupta AK, Cooper EA, Wang T, Polla Ravi S, Lincoln SA, Piguet V, et al. Detection of Squalene Epoxidase Mutations in United States Patients with Onychomycosis: Implications for Management. Journal of Investigative Dermatology. 2023;143(12):2476-2483.e7. doi:10.1016/j.jid.2023.04.032
BibTeX
@article{Gupta2023,
author = {Gupta, Aditya K and Cooper, Elizabeth A and Wang, Tong and Polla Ravi, Shruthi and Lincoln, Sara A and Piguet, Vincent and McCarthy, Laurence R and Bakotic, Wayne L},
title = {Detection of Squalene Epoxidase Mutations in United States Patients with Onychomycosis: Implications for Management},
journal = {Journal of Investigative Dermatology},
year = {2023},
volume = {143},
number = {12},
pages = {2476--2483.e7},
doi = {10.1016/j.jid.2023.04.032}
}
EUVIMED